OneSource Specialty Pharma Limited is an India-based, pure-play CDMO formed from the integration of legacy pharmaceutical and biologics development and manufacturing businesses. With more than three decades of operational experience and consistent regulatory compliance across global markets, the company delivers comprehensive solutions from early-stage development through commercial manufacture. Its team of scientific, technical and techno-commercial professionals operates from multiple state-of-the-art facilities in Bengaluru, India, approved by major regulatory authorities. OneSource provides a wide range of development and manufacturing services designed to support clients in transforming product concepts into market-ready therapies efficiently and effectively.

Key products and services

Biologics development and manufacturing: integrated support for complex biologics, including process and analytical development, tech transfer and scale-up.

Drug-device combination solutions: design, development and manufacture of combination products such as prefilled syringes, auto-injectors and pen injectors.

Complex sterile injectables: formulation and production of advanced sterile dosage forms, including lyophilised vials, cartridges and pre-filled syringes.

Soft gelatin capsule production: development and high-volume manufacturing of soft gel capsule formats in various shapes, sizes and specialised formulations.

End-to-end CDMO services: comprehensive contract development and manufacturing services across early development, clinical, regulatory support and commercial supply.

OneSource’s breadth of technical expertise and integrated manufacturing infrastructure positions it to support pharmaceutical and biotech partners globally. By offering multimodal platforms under one organisational umbrella, it aims to simplify outsourcing, reduce supply-chain complexity and accelerate time-to-market for a range of therapies across multiple therapeutic modalities.